# Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging

> **NCT02041117** · PHASE4 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 162 (actual)

## Conditions studied

- Intracranial Arterial Stenosis

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT02041117
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-24
- **Primary completion:** 2018-11-06
- **Final completion:** 2018-11-06
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02041117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02041117, "Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02041117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*